Skip to main content

Table 1 Clinical characteristics of COPD and control subjects

From: CD8 positive T cells express IL-17 in patients with chronic obstructive pulmonary disease

 

COPD

Controls

Number

16

15

Age

53 ± 6

48 ± 9

Male/Female

10/6

11/4

Current/ex-smokers

7/8

0/3

Post-BD FEV1% predicted

60 ± 18

95 ± 12

TLCO%

60 ± 15

100 ± 20

GOLD Stage

  

   I

2

-

   II

8

-

   III-IV

6

-

Respiratory Medication

  

   SABD

13

-

   LABD

4

-

   ICS

5

-

   Combination (LABD+ICS)

3

-

   Theophylline

0

-

  1. Data are presented as mean ± SD. BD, bronchodilator; FEV1, forced expiratory volume in 1s; TLCO, Transfer Factor of the Lung for Carbon Monoxide; SABD, short-acting bronchodilators; LABD, long-acting bronchodilators; ICS, inhaled corticosteroids.